Dianthus Therapeutics, Inc. (DNTH) vs LifeStance Health Group, Inc. (LFST)

A side-by-side comparison of Dianthus Therapeutics, Inc. and LifeStance Health Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — DNTH vs LFST

growth of $100 · dividends reinvested · last 5y
DNTH -53.1% (-14.0%/yr)LFST -44.2% (-11.0%/yr)LFST compounded faster over this window
050100Start $10020222023202420252026$47$56
DNTH LFST

DNTH vs LFST: by the numbers

  • •DNTH is the larger company ($4.78B vs $4.70B market cap).
  • •LFST is profitable (3.19% net margin) while DNTH runs a net loss (-1570.85%).

Metrics side by side

Valuation

MetricDNTHLFST
P/E ratioN/A93.45
Forward P/EN/A75.50
P/S ratio2508.822.97
P/B ratio4.083.18
EV / EBITDAN/A35.16
FCF yieldN/A3.70%

Profitability

MetricDNTHLFST
Gross margin96.01%33.56%
Operating margin-8739.34%4.95%
Net margin-1570.85%3.19%
ROE-2.55%3.43%
ROIC-18.48%3.03%

Growth (annualized)

MetricDNTHLFST
Revenue CAGR (5Y)N/A24.79%
Total return CAGR (5Y)-5.50%-1.46%

Frequently asked

Is DNTH or LFST more profitable?
LFST runs the higher net margin — DNTH at -1570.85% versus LFST at 3.19%.
How have DNTH and LFST total returns compared?
Over the past 5 years, DNTH delivered -5.50% and LFST delivered -1.46% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.